Polymorphism of Interleukin-6 is not associated with the presence or absence of high HPV E6/E7

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3501-3504

  Porto, Claudia Regina Cinti ^a   De Oliveira Kleine, João Paulo Ferreira ^a   Filho, Adhemar Longatto ^b,c,d,e   Da Silva, Ismael Dale Cotrim Guerreiro ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF MINHO   (Portugal)

^e UNIVERSITY OF MINHO   (Portugal)

Author keywords

E6 E7; Gene polymorphism; HPV; IL6

Indexed keywords

INTERLEUKIN 6; PROTEIN E6; PROTEIN E7; ONCOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WART VIRUS; ALLELE; BIOSYNTHESIS; CASE CONTROL STUDY; DNA POLYMORPHISM; E6/E7; GENETIC POLYMORPHISM; GENETICS; IL6; METABOLISM; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PROMOTER REGION; UTERINE CERVIX; VIROLOGY;

E6/E7; GENE POLYMORPHISM; HPV; IL6;

ADULT; ALLELES; CASE-CONTROL STUDIES; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC;

EID: 84906309110     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Parkin DM and Bray F: Chapter 2: the burden of HPV-related cancers. Vaccine 24: 11-25, 2006.
2. Sichero L and Villa LL: Câncer do Colo do Útero: Biologia do HPV. Tecmedd: 58-66, 2008.
3. Foresta C, Patassini C, Bertoldo A, Menegazzo M, Francavilla F, Barzon L and Ferlin A: Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. Plos One 6: issue 3, 2011.
4. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews Cancer 2: 342-350, 2002.
5. Stoler MH: Human papillomavirus biology and cervical neoplasia: implications for diagnostic criteria and testing. Archives of Pathology & Laboratory Medicine 127: 935-939, 2003.
6. Kim YT and Zhao M: Aberrant cell cycle regulation in cervical carcinoma. Yonsei Medical Journal 46: 597-613, 2005.
7. Trottier H and Franco EL: The epidemiology of genital human papillomavirus infection. Vaccine 24: 4-15, 2006.
8. Koutsky L: Epidemiology of genital human papillomavirus infection. The American Journal of Medicine 102: 3-8, 1997.
9. Motoyama S, Ladines-Llave CA, Villanueva SL and Maruo T: The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe Journal of Medical Sciences 50: 9-19, 2004.
10. Snijders PJF, Steenbergen RDM, Heideman DAM and Meijer CJLM: HPV mediated cervical carcinogenesis: concepts and clinical implications. The Journal of Pathology 208: 152-164, 2006.
11. Villa LL: Câncer do Colo do Útero: Vacinas contra o Papilomavírus Humano (HPV). Tecmedd: 96-100, 2008.
12. Mammas IN, Sourvinos G, Giannoudis A and Spandidos DA: Human papillomavirus and host cellular interactions. Pathology and Oncology Research 14: 345-354, 2008.
13. Scheurer ME, Tortolero-Luna G and Adler-Storthz K: Human papillomavirus infection: biology, epidemiology and prevention. International Journal of Gynecological Cancer 15: 727-746, 2005.
14. Villa LL: Biology of genital human papillomaviruses. International Journal of Gynecology and Obstetrics 94: 3-7, 2006.
15. Rajeevan MS, Swan DC, Nisenbaum R, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, Birdsong G, Husain M, Srivastava S and Unger ER: Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. International Journal of Cancer 115: 114-120, 2005.
16. Ribeiro KCB: Câncer do Colo do Útero: Câncer do Colo do Útero: Epidemiologia do Câncer do Colo do Útero - Fatores Demográficos e fatores de Risco. Tecmedd: 18-23, 2008.
17. Woodworth CD and Simpson S: Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. American Journal of Pathology 142: 1544-1555, 1993.
18. Souza NC, Brenna SMF, Campos F, Syrjanen KJ, Baracat EC and Silva IDCG: Interleukin-6 polymorphism and the risk of cervical câncer. International Journal of Gynecological Cancer 16: 1-5, 2006.
19. www.genome.gov/gwastudies
20. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE and Powell JT: Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103: 2260-2265, 2001.
21. Basso F, Lowe GD, Rumley A, McMahon AD and Humphries SE: Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arteriosclerosis, Thrombosis, and Vascular Biology 22: 599-604, 2002.
22. Tartour E, Gey A, Sastre-Garau X, Pannetier C, Mosseri V, Kourilsky P and Fridman WH: Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. International Journal of Cancer 54: 6243-6248, 1994.
23. Shi TY, Zhu ML, He J, Wang MY, Li QX, Zhou XY, Sun MH, Shao ZM, Yu KD, Cheng X, Wu X and Wei Q: Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. Human Genetics 132: 301-312, 2013.
24. Grimm C, Watrowski R, Baumühlner K, Natter C, Tong D, Wolf A, Zeillinger R, Leodolter S, Reinthaller A and Hefler L: Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecologic Oncology 121: 537-541, 2011.
25. Gangwar R, Mittal B and Mittal RD: Association of interleukin-6-174G>C promoter polymorphism with risk of cervical cancer. The International Journal of Biological Markers 24: 11-16, 2009.